Retaglutide is a novel GLP-1 receptor agonist currently under research for the control of obesity. This drug works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that https://albiejcbh897064.bloggazzo.com/37792779/retaglutide-a-promising-glp-1-receptor-agonist